诺和诺德:论点正确,只是股票尚未察觉
· seekingalpha.com
分析师维持诺和诺德的强力买入评级,基于10.89倍的非GAAP市盈率,且自由现金流指引上调至600-700亿丹麦克朗。
It has been nearly 3 months since I last covered a long-time holding of mine, Novo Nordisk ( NVO ), as last time I kept my Strong Buy rating following the Q2
A...